Concepedia

Sarah Alter

SA

Statistics

Publications

11

Citations

1K

H-Index

11

Active since

2013

Affiliations

Altor BioScience (United States)(Current)

University of Wisconsin–Madison

University of Miami

National Institutes of Health

Center for Cancer Research

Sarah Alter is an author at Altor BioScience (United States) specializing in immunology, medicine, and immunotherapy.

Top concepts

Publications per year

2013–2019

11

Publications

11

Comparison of the Superagonist Complex, ALT-803, to IL15 as Cancer Immunotherapeutics in Animal Models

Peter R. Rhode, Jack O. Egan, Wenxin Xu et al. · Cancer Immunology Research · 2015 · 220 citations · Full text

, , +19

In senescence, age‐associated B cells secrete <scp>TNF</scp>α and inhibit survival of B‐cell precursors*

Michelle Ratliff, Sarah Alter, Daniela Frasca et al. · Aging Cell · 2013 · 173 citations · Full text

, , +26

IL-15 superagonist/IL-15RαSushi-Fc fusion complex (IL-15SA/IL-15RαSu-Fc; ALT-803) markedly enhances specific subpopulations of NK and memory CD8+ T cells, and mediates potent anti-tumor activity against murine breast and colon carcinomas

Peter Kim, Anna Kwilas, Wenxin Xu et al. · Oncotarget · 2016 · 155 citations · Full text

, , +20

Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy

Karin M. Knudson, Kristin C. Hicks, Sarah Alter et al. · Journal for ImmunoTherapy of Cancer · 2019 · 110 citations · Full text

Therapeutic administration of IL-15 superagonist complex ALT-803 leads to long-term survival and durable antitumor immune response in a murine glioblastoma model

Dimitrios Mathios, Chul‐Kee Park, Warren D. Marcus et al. · International Journal of Cancer · 2015 · 102 citations · Full text

, , +25

1–5 of 11